Form D Explorer

Inspect source fieldsReport a record issue

Form D — Duo Oncology Inc.

0001843372-25-000002 · filed Jun 10, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$3,000,000
Reported amount sold
$400,000
Minimum investment
$25,000
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Duo Oncology Inc.
CIK
1843372
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
218 OAKLAND AVE
PITTSBURGH, Pennsylvania 15213
Phone
412-709-1659

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗